Yanpeng Liu

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit

Jie Wang, Keke Fei, Jing Hua et al. · mAbs · 2019 · 148 citations · Full text

Immunology, Immunoediting, Pathology +24

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity

Yunqian Qiao, Yangmin Qiu, Jie Ding et al. · Nature Communications · 2021 · 39 citations · Full text

Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis

Yanpeng Liu, Peng Yu, Peng Xu et al. · Journal of Controlled Release · 2019 · 38 citations

Medicine, Osteoarthritis, Pharmacotherapy +5

Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity

Hui Shang, Anna Zhou, Jian Jiang et al. · Acta Biomaterialia · 2018 · 31 citations

Amyloidogenic Human Calcitonin, Biochemistry, Medicine +6

Spatiotemporally controlled calcitonin delivery: Long-term and targeted therapy of skeletal diseases

Peng Yu, Yanpeng Liu, Jing Xie et al. · Journal of Controlled Release · 2021 · 29 citations

Skeletal Diseases, Medicine, Osteoporosis +6